Metlife (DE:MWZ)
XETRA:MWZ

Metlife (MWZ) Stock Price & Analysis

0 Followers

MWZ Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€45.48 - €73.63
Previous Close€49.41
Volume0.00
Average Volume (3M)150.00
Market Cap
$40.57B
Enterprise Value€55.55B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$18.65B
Price to Earnings (P/E)N/A
Beta0.44
Aug 02, 2023
2.02 (3.81%)
Share Statistics
EPS (TTM)N/A
Shares Outstanding765,820,886
10 Day Avg. Volume146
30 Day Avg. Volume150
Standard Deviation0.07
R-Squared0.17
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.51
Price to Sales (P/S)2.65
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.80
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda216.15
Forecast
Price Target Upside― Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9


Financials

Annual

MWZ FAQ

What was Metlife’s price range in the past 12 months?
Metlife lowest stock price was €45.48 and its highest was €73.63 in the past 12 months.
    What is Metlife’s market cap?
    Currently, no data Available
    When is Metlife’s upcoming earnings report date?
    Metlife’s upcoming earnings report date is Aug 02, 2023 which is in 58 days.
      How were Metlife’s earnings last quarter?
      Metlife released its earnings results on May 03, 2023. The company reported €1.42 earnings per share for the quarter, missing the consensus estimate of €1.695 by -€0.275.
        Is Metlife overvalued?
        According to Wall Street analysts Metlife’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Metlife pay dividends?
          Metlife pays a Quarterly dividend of €0.48 which represents an annual dividend yield of 3.81%. See more information on Metlife dividends here
            What is Metlife’s EPS estimate?
            Metlife’s EPS estimate is €1.92.
              How many shares outstanding does Metlife have?
              Currently, no data Available
              What happened to Metlife’s price movement after its last earnings report?
              Metlife reported an EPS of €1.42 in its last earnings report, missing expectations of €1.695. Following the earnings report the stock price went down -9.192%.
                Which hedge fund is a major shareholder of Metlife?
                Among the largest hedge funds holding Metlife’s share is Dodge & Cox. It holds Metlife’s shares valued at 3B.

                  ---

                  Metlife Stock Smart Score

                  The Metlife Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Metlife

                  Headquartered in New York, MetLife, Inc. is among the largest global providers of insurance and financial services to individual and institutional customers. It offers life insurance, annuities, employee benefits and asset management services. The company operates through the following segments: U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Metlife
                  American Equity Investment Life
                  American Financial Group
                  American International Group
                  Allstate

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis